Healthcare provider profile · identity verified

Raymond Lachlan Steele, DO

Internal Medicine · VENICE, FL · NPI 1356881585

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	801	250
Amlodipine Besylate	Amlodipine Besylate	561	168
Levothyroxine Sodium	Levothyroxine Sodium	535	143
Losartan Potassium	Losartan Potassium	420	121
Rosuvastatin Calcium	Rosuvastatin Calcium	416	122
Lisinopril	Lisinopril	373	110
Pantoprazole Sodium	Pantoprazole Sodium	288	94
Metoprolol Succinate	Metoprolol Succinate	240	74
Omeprazole	Omeprazole	232	66
Tamsulosin Hcl	Tamsulosin Hcl	223	75
Hydrochlorothiazide	Hydrochlorothiazide	205	69
Metformin Hcl	Metformin Hcl	192	60
Gabapentin	Gabapentin	183	67
Simvastatin	Simvastatin	181	50
Allopurinol	Allopurinol	177	53
Meloxicam	Meloxicam	167	78
Mounjaro	Tirzepatide	167	30
Pravastatin Sodium	Pravastatin Sodium	165	48
Methylprednisolone	Methylprednisolone	160	134
Trazodone Hcl	Trazodone Hcl	153	57
Escitalopram Oxalate	Escitalopram Oxalate	151	47
Potassium Chloride	Potassium Chloride	121	34
Montelukast Sodium	Montelukast Sodium	119	36
Metoprolol Tartrate	Metoprolol Tartrate	113	37
Eliquis	Apixaban	106	36
Sertraline Hcl	Sertraline Hcl	103	30
Alendronate Sodium	Alendronate Sodium	95	33
Clopidogrel	Clopidogrel Bisulfate	92	32
Duloxetine Hcl	Duloxetine Hcl	89	28
Irbesartan	Irbesartan	89	23
Chlorthalidone	Chlorthalidone	87	25
Clonazepam	Clonazepam	87	32
Ozempic	Semaglutide	85	24
Albuterol Sulfate Hfa	Albuterol Sulfate	83	36
Zolpidem Tartrate	Zolpidem Tartrate	79	35
Ezetimibe	Ezetimibe	75	26
Alprazolam	Alprazolam	73	23
Tramadol Hcl	Tramadol Hcl	73	26
Spironolactone	Spironolactone	72	22
Fluticasone Propionate	Fluticasone Propionate	71	29
Metformin Hcl Er	Metformin Hcl	71	24
Glimepiride	Glimepiride	70	20
Citalopram Hbr	Citalopram Hydrobromide	68	22
Carvedilol	Carvedilol	63	17
Finasteride	Finasteride	63	24
Furosemide	Furosemide	59	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Glipizide Er	Glipizide	56	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	17
Azelastine Hcl	Azelastine Hcl	55	27
Ramipril	Ramipril	51	14
Celecoxib	Celecoxib	49	18
Fluoxetine Hcl	Fluoxetine Hcl	49	13
Azithromycin	Azithromycin	46	40
Atenolol	Atenolol	44	12
Synthroid	Levothyroxine Sodium	43	11
Enalapril Maleate	Enalapril Maleate	42	13
Farxiga	Dapagliflozin Propanediol	42	16
Prednisone	Prednisone	42	26
Buspirone Hcl	Buspirone Hcl	41	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	28
Oxybutynin Chloride Er	Oxybutynin Chloride	40	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	12
Doxycycline Hyclate	Doxycycline Hyclate	39	32
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	32
Valacyclovir	Valacyclovir Hcl	39	24
Estradiol	Estradiol	38	17
Testosterone Cypionate	Testosterone Cypionate	38	11
Paroxetine Hcl	Paroxetine Hcl	37	12
Valsartan	Valsartan	37	12
Glipizide	Glipizide	36	12
Memantine Hcl	Memantine Hcl	36	11
Famotidine	Famotidine	35	12
Lovastatin	Lovastatin	35	suppressed
Donepezil Hcl	Donepezil Hcl	34	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	13
Propranolol Hcl	Propranolol Hcl	33	12
Bupropion Xl	Bupropion Hcl	32	11
Fenofibrate	Fenofibrate	32	suppressed
Lorazepam	Lorazepam	32	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	29
Cephalexin	Cephalexin	31	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Xarelto	Rivaroxaban	30	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Pregabalin	Pregabalin	28	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Primidone	Primidone	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Fluconazole	Fluconazole	22	19
Januvia	Sitagliptin Phosphate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	20
Vascepa	Icosapent Ethyl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Torsemide	Torsemide	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	11
Acyclovir	Acyclovir	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Np Thyroid	Thyroid,pork	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Testosterone	Testosterone	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Praluent Pen	Alirocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error